跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
VARILRIX HSA-FREE varicella vaccine live attenuated 0.5mL injection vial plus diluent ampoule composite pack - TGA Drug Approval Details
Approvals
/
TGA
/
VARILRIX HSA-FREE varicella vaccine live attenuated 0.5mL injection vial plus diluent ampoule composite pack
Approved
STANDARD
VARILRIX HSA-FREE varicella vaccine live attenuated 0.5mL injection vial plus diluent ampoule composite pack
GlaxoSmithKline Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
9c4ff6022c02c373
Company
GlaxoSmithKline Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
9c4ff6022c02c373
Product Name
VARILRIX HSA-FREE varicella vaccine live attenuated 0.5mL injection vial plus diluent ampoule composite pack
Artg Id
234751
Artg Name
VARILRIX HSA-FREE varicella vaccine live attenuated 0.5mL injection vial plus diluent ampoule composite pack
Sponsor
GlaxoSmithKline Australia Pty Ltd
Company Detail Path
/organization/glaxosmithkline-australia-pty-ltd
Artg Date
2015-04-16
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2016-CMI-02371-1
Product Information
http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2015-PI-01641-1
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
9c4ff6022c02c373
Type
Standard
Back to TGA Approvals